Germany · Investor

Wellington Partners

Last cheque observed Jun 2026; 180 cheques on record.

Deploying nowVC firm

SeedSeries ASeries BLife ScienceTherapeuticsMedical Devices

Deploying now
50%of best year6cheques in 12 months, 180 on record
Since the last cheque152days00hrs00min00sec
Median round$33MCheque size, as they say$200K – $15MRounds led3 of 180Sole investor18 roundsExits18 from the portfolioMostly inGermany, 27%
Pitch Wellington Partners

Wellington Partners highlights

  1. 01

    6 cheques in the last 12 months

  2. 02

    Mostly Series A and Series B: 55% of its rounds

  3. 03

    Sole investor in 18 rounds, median $4.7M

  4. 04

    18 exits from the portfolio

What they do

A leading European Venture Capital firm investing in early- and growth-stage Life Science companies.From their own website
Type
VC firm (from a list, unverified)
Cheque size
$200K – $15M as they say
Stages
SeedSeries ASeries BGrowth
Sectors
Life ScienceTherapeuticsMedical Devices
Based in
Munich, Germany
Cold pitches
Not accepted

The record

Every round we can evidence, newest first180 appearances

  1. 2026

    6 rounds

  2. Jun
    Beren TherapeuticsDebt · US$165MWith 3 others
  3. Mar
    Nadia CareSeries A · US · Firms' own news pages$12MWith 7 others
  4. Mar
    Polares MedicalSeries C · US$50MWith 2 others
  5. Feb
    SidekickSeries A · GB · Eos Venture Partners$11MWith 12 others
  6. Feb
    nyra healthSeries A · AT$24MWith 2 others
  7. Jan
    TricaresDebt · FR$23MWith 4 others
  8. 2025

    8 rounds

  9. Oct
    OnwardNL$58MWith 2 others
  10. Oct
    Confo TherapeuticsGrant · BE$1.2MWith 3 others
  11. Aug
    SNIPRSeries B · DK · Firms' own news pages$41MWith 5 others
  12. Jul
  13. May
    HiloSeries B · CH$42MWith 4 others
  14. May
  15. Apr
    HepaRegeniXVenture · DE$24MWith 2 others
  16. Mar
    AMBOSSVenture · DE$259MWith 4 others
  17. 2024

    10 rounds

  18. Oct
    AignosticsSeries B · DE$34MWith 3 others
  19. Sept
    CorFlow TherapeuticsSeries B · CH$49MSole investor
  20. Aug
    ImCheck TherapeuticsGrant · FR$22MWith 6 others
  21. Aug
    Sphingotec GmbHSeries C · DE$5.5MSole investor
  22. Jul
    Confo TherapeuticsSeries B · BE · Capricorn Partners$65MWith 12 others
  23. Jul
    SciRhomSeries A · DE$68MWith 3 others
  24. May
    NostoSecondary · FI$7.6MWith 4 others
  25. Apr
    Seamless TherapeuticsSeed · DE$13MWith 1 other
  26. Mar
    Cayaba CareVenture · US$4.4MWith 3 others
  27. Feb
    MMISeries C$110MWith 4 others
  28. 2023

    3 rounds

  29. Oct
    MinervaxVenture · DK$57MWith 5 others
  30. Jun
    SoundtrackVenture · SE$15MWith 3 others
  31. Apr
    Koa HealthVenture · ESUndisclosedWith 1 other
  32. 2022

    5 rounds

  33. Sept
    Carisma TherapeuticsSeries C · US$30MWith 3 others
  34. Sept
    Latana Brand TrackingSeries B · DE$36MWith 2 others
  35. Apr
    ArtfinderCrowdfunding · GB$565KWith 3 others
  36. Mar
    TonsserVenture · DKUndisclosedWith 3 others
  37. Mar
    AYOXXAVenture · DEUndisclosedWith 1 other
  38. 2021

    3 rounds

  39. Dec
    UNIONSeries B · US$22MWith 2 others
  40. Oct
    IOmx TherapeuticsSeries B · DE$75MWith 1 other
  41. Jan
    IconOVir BioSeries A$77MWith 2 others
  42. 2020

    1 round

  43. Oct
    FesticketCrowdfunding$3KWith 4 others
  44. 2019

    6 rounds

  45. Dec
    ImCheck TherapeuticsSeries B · FR · FinSMEs$53MWith 9 others
  46. Nov
    eGenesisSeries B · US · FinSMEs$100MWith 6 others
  47. Sept
    AmbossSeries B · DE · TechCrunch$33MWith 4 others
  48. Sept
    STipe TherapeuticsSeries A · DK · FinSMEs$22MWith 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 29 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$361Mgross assets of its fundsOct 2026
6+funds on filenumbered funds in its name
Exemptreporting adviserventure or small private funds
Legal name
Wellington Partners LIFE Science Venture Capital Management GMBH
SEC number
CRD 333839

Exits from the portfolio

Companies it backed that were later bought or listed18 in all

MapillaryBought by FacebookUndisclosedJun 2020
ProximicBought by comScoreUndisclosedMay 2015
DefiniensBought by MedImmune$150MNov 2014
SapiensBought by Medtronic$200MAug 2014
Adconion Media GroupBought by Amobee$235MJun 2014
ReadmillBought by DropboxUndisclosedMar 2014
Oxford ImmunotecListed$64MNov 2013
QypeBought by Yelp$50MOct 2012
SeesmicBought by HootsuiteUndisclosedSept 2012
EmberBought by Silicon Laboratories$72MMay 2012
MTM LaboratoriesBought by RocheUndisclosedJul 2011
BridgeCoBought by SMSCUndisclosedMay 2011
AstaroBought by SophosUndisclosedMay 2011
amiandoBought by XING$14MDec 2010
AloqaBought by Motorola SolutionsUndisclosedSept 2010
Q-LayerBought by Sun MicrosystemsUndisclosedJan 2009
VoiceObjectsBought by VoxeoUndisclosedDec 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Wellington Partners. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Wellington Partners put money into.

On podcasts

1 episode naming Wellington Partners in the title, and 1 more that mention it.

Mentioned in

Quick answers about Wellington Partners

What does Wellington Partners invest in?

Wellington Partners invests most often at Series A and Series B (55% of the rounds on record), in sectors such as Life Science, Therapeutics and Medical Devices.

How active is Wellington Partners?

180 investments on record, 6 of them in the last 12 months, and it led 3. The most recent was in Jun 2026.

What has Wellington Partners invested in recently?

Its most recent investments on record: Beren Therapeutics (Debt, Jun 2026), Nadia Care (Series A, Mar 2026) and Polares Medical (Series C, Mar 2026).

How big are Wellington Partners's cheques?

The median round it joins is $33M. It says it writes cheques of $200K to $15M.

Does Wellington Partners lead rounds?

Sometimes: it led 3 of its 180 investments on record (2%).

Where does Wellington Partners invest?

Most of the companies it backs are in Germany (27%), the United States (19%) and Denmark (11%).

Is Wellington Partners investing now?

Yes: it is actively investing, with 6 investments in the last 12 months.

Who does Wellington Partners invest alongside?

Most often Balderton Capital (9 rounds together), Boehringer Ingelheim Venture Fund (7 rounds together) and Earlybird Venture Capital (7 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it